Article

Top 5 bladder cancer articles of 2017

A look at Urology Times' most-read articles on bladder cancer reveals a variety of topics, ranging from radical cystectomy to the role of protein- and cell-based urinary biomarkers for bladder cancer detection and surveillance.

A look at Urology Times' most-read articles on bladder cancer reveals a variety of topics, ranging from radical cystectomy to the role of protein- and cell-based urinary biomarkers for bladder cancer detection and surveillance. As part of our review of 2017, these are our top 5 most-read articles on bladder cancer:

Radical cystectomy for bladder cancer: Tools vs. technique

Robert Abouassaly, MD, MS, discusses important principles of radical cystectomy, whether performed using the open, laparoscopic, or robotic approach. Read more

Novel bladder Ca agent shows promise in phase II trial

An investigatory bladder cancer agent was associated with a 12-month high-grade recurrence-free survival of 35% for patients with Ta/T1 disease, researchers reported. Read more

Robotic vs. open cystectomy: How PFS, OS compare

Evaluation of upper tract surveillance for high-grade NMIBC and evidence that androgen receptor activity may be related to recurrence of bladder cancer were among other take-home messages from AUA 2017. Read more

Bladder cancer test shows high sensitivity

The noninvasive molecular test for detecting recurrent urothelial carcinoma also demonstrates high negative predictive value in a prospective study. Read more

Biomarkers for bladder cancer: Current and future

The role of protein- and cell-based urinary biomarkers for bladder cancer detection and surveillance is controversial, and in 2017 these assays have yet to come into widespread use among urologists. Their uptake is expected to increase, however, considering that the American Urological Association/Society of Urologic Oncology “Guideline on Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer” that was released in 2016 identifies situations for using urinary biomarkers, according to Badrinath R. Konety, MD. Read more

More from Urology Times:

Top 5 Dr. Rosevear blogs of 2017

Top 9 peer-reviewed prostate cancer papers of 2017

Top 12 practice management articles of 2017

To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.

Related Videos
Interpreting ART toxicity and tolerability for bladder cancer, with Vedang Murthy, MD
Daniel Carson, MD, MS, answers a question during a Zoom video interview
Trinity Bivalacqua, MD, PhD, and Mark Tyson, MD, MPH, experts on bladder cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.